These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27838623)

  • 1. Proportion and Characteristics of US Adults Who May Be Eligible From Additional Blood Pressure Lowering Based on Absolute Risk.
    Odutayo AA; Tennankore KK; Emdin CA
    Am J Hypertens; 2017 Mar; 30(3):232-235. PubMed ID: 27838623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing Cardiovascular Risk to Guide Hypertension Diagnosis and Treatment.
    Navar AM; Pencina MJ; Peterson ED
    JAMA Cardiol; 2016 Nov; 1(8):864-871. PubMed ID: 27604060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Deaths Averted and Serious Adverse Events Incurred From Adoption of the SPRINT (Systolic Blood Pressure Intervention Trial) Intensive Blood Pressure Regimen in the United States: Projections From NHANES (National Health and Nutrition Examination Survey).
    Bress AP; Kramer H; Khatib R; Beddhu S; Cheung AK; Hess R; Bansal VK; Cao G; Yee J; Moran AE; Durazo-Arvizu R; Muntner P; Cooper RS
    Circulation; 2017 Apr; 135(17):1617-1628. PubMed ID: 28193605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generalizability of SPRINT Results to the U.S. Adult Population.
    Bress AP; Tanner RM; Hess R; Colantonio LD; Shimbo D; Muntner P
    J Am Coll Cardiol; 2016 Feb; 67(5):463-72. PubMed ID: 26562046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Hypertension Management Strategies in SPRINT-Eligible US Adults: A Simulation Study.
    Zhang F; Bryant KB; Moran AE; Zhang Y; Cohen JB; Bress AP; Sheppard JP; King JB; Derington CG; Weintraub WS; Kronish IM; Shea S; Bellows BK
    J Am Heart Assoc; 2024 Jan; 13(2):e032370. PubMed ID: 38214272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systolic Blood Pressure Intervention Trial (SPRINT) and Target Systolic Blood Pressure in Future Hypertension Guidelines.
    Egan BM; Li J; Wagner CS
    Hypertension; 2016 Aug; 68(2):318-23. PubMed ID: 27354422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Applicability of the Systolic Blood Pressure Intervention Trial (SPRINT) to the Canadian Population.
    Leung AA; Chang HJ; McAlister FA; Khan NA; Rabi DM; Quan H; Padwal RS
    Can J Cardiol; 2018 May; 34(5):670-675. PubMed ID: 29731026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the Association of the 2017 and 2014 Hypertension Guidelines With Cardiovascular Events and Deaths in US Adults: An Analysis of National Data.
    Bundy JD; Mills KT; Chen J; Li C; Greenland P; He J
    JAMA Cardiol; 2018 Jul; 3(7):572-581. PubMed ID: 29800138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proportion of US adults potentially affected by the 2014 hypertension guideline.
    Navar-Boggan AM; Pencina MJ; Williams K; Sniderman AD; Peterson ED
    JAMA; 2014 Apr; 311(14):1424-9. PubMed ID: 24682242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study.
    Li C; Chen K; Cornelius V; Tomeny E; Wang Y; Yang X; Yuan X; Qin R; Yu D; Wu Z; Wang D; Chen T
    PLoS Med; 2021 Mar; 18(3):e1003515. PubMed ID: 33661907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Eligibility Criteria for the Systolic Blood Pressure Intervention Trial in US Adults Among Excluded Groups: Age <50 Years, Diabetes Mellitus, or a History of Stroke.
    Bress AP; Tanner RM; Hess R; Gidding SS; Colantonio LD; Shimbo D; Muntner P
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27405811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Level of Blood Pressure Control and Cardiovascular Events: SPRINT Criteria Versus the 2014 Hypertension Recommendations.
    Ko MJ; Jo AJ; Park CM; Kim HJ; Kim YJ; Park DW
    J Am Coll Cardiol; 2016 Jun; 67(24):2821-31. PubMed ID: 27311520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Eligibility and subsequent burden of cardiovascular disease of four strategies for blood pressure-lowering treatment: a retrospective cohort study.
    Herrett E; Gadd S; Jackson R; Bhaskaran K; Williamson E; van Staa T; Sofat R; Timmis A; Smeeth L
    Lancet; 2019 Aug; 394(10199):663-671. PubMed ID: 31353050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Intensive Blood Pressure Lowering on Cardiovascular Outcomes: A Systematic Review Prepared for the 2020 U.S. Department of Veterans Affairs/U.S. Department of Defense Guidelines.
    D'Anci KE; Tipton K; Hedden-Gross A; Rouse B; Hermanson L; Fontanarosa J
    Ann Intern Med; 2020 Dec; 173(11):895-903. PubMed ID: 32866419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of blood pressure lowering on outcome incidence in hypertension: 7. Effects of more vs. less intensive blood pressure lowering and different achieved blood pressure levels - updated overview and meta-analyses of randomized trials.
    Thomopoulos C; Parati G; Zanchetti A
    J Hypertens; 2016 Apr; 34(4):613-22. PubMed ID: 26848994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled trials of blood pressure lowering in hypertension: a critical reappraisal.
    Zanchetti A; Thomopoulos C; Parati G
    Circ Res; 2015 Mar; 116(6):1058-73. PubMed ID: 25767290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimated Population Health Benefits of Intensive Systolic Blood Pressure Treatment Among SPRINT-Eligible US Adults.
    Derington CG; Bress AP; Berchie RO; Herrick JS; Shen J; Ying J; Greene T; Tajeu GS; Sakhuja S; Ruiz-Negrón N; Zhang Y; Howard G; Levitan EB; Muntner P; Safford MM; Whelton PK; Weintraub WS; Moran AE; Bellows BK
    Am J Hypertens; 2023 Aug; 36(9):498-508. PubMed ID: 37378472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Hypertension and Cardiovascular Risk According to Blood Pressure Thresholds Used for Diagnosis.
    Lamprea-Montealegre JA; Zelnick LR; Hall YN; Bansal N; de Boer IH
    Hypertension; 2018 Sep; 72(3):602-609. PubMed ID: 30354757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure targets and absolute cardiovascular risk.
    Odutayo A; Rahimi K; Hsiao AJ; Emdin CA
    Hypertension; 2015 Aug; 66(2):280-5. PubMed ID: 26056340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Achieved Blood Pressure on First Stroke in Uncomplicated Grade 1 Hypertension.
    Qin X; Li Y; Sun N; He M; Tang G; Yin D; Wang J; Liang M; Wang B; Huo Y; Xu X; Xu X; Hou FF
    J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28275067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.